Megakaryocytic Leukemia and Platelet Factor 4

References

• Von Boros J., Korenyi A. Über einen Fall von akuter Megakaryoblastenleukämie, zugleich einige Bemerk-ungen zum Problem der akuten Leukämie. Z. Klin Med. 1931; 118: 697
   Google Scholar
• Breton-Gorius J., Vanhaeke D., Pryzwansky K. B., Guichard J., Tabilio A., Vainchenker W., Carmel R. Simultaneous detection of membrane markers with monoclonal antibodies and peroxidatic activities in leukaemia: Ultra-structural analysis using a new method of fixation preserving the platelet peioxidase. Brit. I. Hematol. 1984; 58: 447–458
   PubMed Web of Science ®Google Scholar
• Huang M., Li C., Nichols W. L., Young J., Katzmann J. A. Acute leukemia with megakaryocytic differentiation: A study of 12 cases identified immunocytochemically. Blood 1984; 64: 427–439
   PubMed Web of Science ®Google Scholar
• Ruiz-argüelles G. J., Marin-Lopez A., Lobato-Mendizábal E., Ruiz-Argüelles A., Nichols W. L., Katzman A. Acute megakaryoblastic leukaemia: A prospective study of its identification and treatment. Brit. J. Haematol. 1986; 62: 55–63
   PubMed Web of Science ®Google Scholar
• Benett J. M., Catovsky D., Daniel M., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocytic leukemia (M7). Ann. Intern. Med. 1985; 103: 460–462
   PubMed Web of Science ®Google Scholar
• Second MIC Cooperative Study Group. Morphological, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genet. Cytogenet. 1988; 30: 1–15
   PubMed Web of Science ®Google Scholar
• Cheson B. D., Cassileth P. A., Head D. R., Schiffer C. A., Bennett J. M., Bloomfield C. D., Brunning R., Gale R. P., Grever M. R., Keating M. J., Sawitsky A., Stass S., Weinstein H., Woods W. G. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J. Clin. Oncol. 1990; 8: 813–819
   PubMed Web of Science ®Google Scholar
• Ryo R., Adachi M., Sugano W., Yasunaga M., Yoshida A., Jikai J., Saigo K., Yamaguchi N., Akita H., Yokoyama M., Konaka Y., Poncz M. Platelet factor 4 mRNA expression in cells from a patient with megakaryoblastic crisis of myelogeneous leukemia. Cancer 1991; 67: 960–964
   PubMed Web of Science ®Google Scholar
• Adachi M., Ryo R., Yoshida A., Yamaguchi N., Izumi Y. Refractory anemia terminating in acute megakaryoblastic leukemia (M7). Acta Haematol. 1989; 81: 104–108
   PubMed Web of Science ®Google Scholar
• Cuneo A., Mecucci C., Kerim S., Vandenberghe E., Cin P. D., Van Orshoven A., Rodhain J., Bosly A., Michaux J., Martiat P., Boogaerts M., Carli M. G., Castoldi G., Van Den Berghe H. Multipotent stem cell involvement in megakaryoblastic leukemia: Cytologic and cytogenetic evidence in 15 patients. Blood 1989; 74: 1781–1790
   PubMed Web of Science ®Google Scholar
• San Miguel J. F., Gonzalez M., Canizo M. C., Ojeda E., Orfao A., Caballero M. D., Moro M. J., Fisac P., Borrasca A. L. Leukemia with megakryoblastic involvement: Clinical, hematologic, and immunologic characteristics. Blood 1988; 72: 402–407
   PubMed Web of Science ®Google Scholar
• Najfeld V., Zucker-Franklin D., Adamson J., Singer J., Troy K., Fialkow P. J. Evidence for clonal development and stem cell origin of M7 megakaryocytic leukemia. Leukemia 1988; 2: 351–357
   PubMed Web of Science ®Google Scholar
• Bearman R. M., Pangalis G. A., Rappaport H. Acute (“Malignant”) myelosclerosis. Cancer 1979; 43: 279–293
   PubMed Web of Science ®Google Scholar
• Den Ottolander G. J., Velde J., Brederoo P., Geraedts J. P. M., Slee P. H. T., Willemze R., Zwaan F. E., Haak H. L., Muller H. P., Bieger R. Megakryoblastic leukemia (Acute myelofibrosis): A report of three cases. Brit. J. Haematol. 1979; 42: 9–20
   PubMed Web of Science ®Google Scholar
• Velez-Garcia E. O., Fradera J., Telmont M. L., White J. G. Megakryoblastic transformation of Ph positive chronic granulocytic leukemia. Am. J. Clin. Pathol. 1985; 84: 228–233
   PubMed Web of Science ®Google Scholar
• Coulombel L., Derycke M., Villeval J. L., Leonard C., Breton-Gorius J., Vial M., Bourgeois P., Tchernia G. Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder. Brit. J. Haematol. 1987; 66: 69–76
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Eguchi M., Sugita K., Nakazawa S., Sato T., Kojima S., Bessho F., Konishi S., Inaba T., Hanada R., Yamamoto K. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Blood 1988; 72: 15–23
   PubMed Web of Science ®Google Scholar
• Breton-Gorius J., Reyes F., Duhamel G., Najman A., Gorin N. C. Megakryoblastic acute leukemia: Identification by the ultra structural demonstration of platelet peroxidase. Blood 1978; 51: 45–60
   PubMed Web of Science ®Google Scholar
• Breton-Gorius J., Vainchenker W. Expression of platelet proteins during the in vitro and in vivo differentiation of megakaryocytes and morphological aspects of their maturation. Semin. Hematol. 1986; 23: 43–67
   PubMed Web of Science ®Google Scholar
• Breton-Gorius J., Villeval J. L., Mitjavila M. T., Vinci G., Guichard J., Rochant H., Flandrin G., Vaichenker W. Ultra structural and cytochemical characterization of blasts from early erythroblastic leukemias. Leukemia 1987; 3: 173–181
   Google Scholar
• Martin D. I. K., Zon L. I., Mutter G., Orkin S. H. Expression of an erythroid transcrition factor in megakaryocytic and mast cell lineages. Nature 1990; 344: 444–447
   PubMed Web of Science ®Google Scholar
• Romeo P., Prandini M., Joulin V., Mignotte V., Prenant M., Vainchenker W., Marguerie G., Uzan G. Megakaryocytic and erythrocytic lineages share specific transcrition factors. Nature 1990; 344: 447–449
   PubMed Web of Science ®Google Scholar
• Vinci G., Tabilio A., Deschamps J. F., Van Haeke D., Henri A., Guichard J., Tetteroo P., Lansdorp P. M., Hercend T., Vaichenker W., Breton-Gorius J. Immunological study of in vitro maturation of human megakaryocytes. Brit. J. Haematol. 1984; 56: 589–605
   PubMed Web of Science ®Google Scholar
• Duperray A., Troesch A., Berthier R., Chagnon E., Frachet P., Uzan G., Marguerie G. Biosynthesis and assembly of platelet GPIIb-IIIa in human megakaryocytes: Evidence that assembly between pro-GPIIb and GPIIIa is a prerequisite for expression of the complex on the cell surface. Blood 1989; 74: 1603–1611
   PubMed Web of Science ®Google Scholar
• Sakaguchi M., Sato T., Groopan J. E. Human deficiency virus infection of megakaryocytic cells. Blood 1991; 77: 481–485
   PubMed Web of Science ®Google Scholar
• Imamura N., Inada T., Mtasiwa D. M., Kuramoto A. Demonstration of thrombospondin(TSP) receptor on the cell surface of acute megakaryoblastic leukemia. Am. J. Hematol. 1989; 31: 142–143
   PubMed Web of Science ®Google Scholar
• Imamura N., Mtasiwa D. M., Ota H., Inada T., Kuramoto A. Distribution of cell surface glycoprotein CD9(P24) antigen on megakaryocyte lineage leukemias and cell lines. Am. J. Hematol. 1990; 35: 65–67, 1990.
   PubMed Web of Science ®Google Scholar
• Koike T., Aoki S., Maruyama S., Narita M., Lshizuka T., Imanaka H., Adachi T., Maeda H., Shibata A. Cell surface phenotyping of megakaryoblasts. Blood 1987; 69: 957–960
   PubMed Web of Science ®Google Scholar
• Yoshida A., Ryo R., Yamaguchi N., Okuma M. Expression of P52, a putative collagen receptor, on human megakaryocytic leukemia cells. Leuk. & Lymph. 1992; 6: 191–196
   Web of Science ®Google Scholar
• Ishibashi T., Kimura H., Uchida T., Kariyone S., Friese P., Burstein S. A. Human interleukin 6 is a direct promotor of maturation of megakaryocytes in vitro. Proc. Natl. Acad. Sci. USA 1989; 86: 5953–5957
   PubMed Web of Science ®Google Scholar
• Navarro S., Debili N., Le Couedic J., Klein B., Breton-Gorius J., Doly J., Vainchenker W. Interleukin-6 and its receptor are expressed by human megakaryocytes: In vitro effects on proliferation and endoreplication. Blood 1991; 77: 461–471
   PubMed Web of Science ®Google Scholar
• Navarro S., Teresa M., Katz A., Doly J., Vainchenker W. Expression of interleukin 6 and its specific receptor by untreated and PMA-stimulated human erythroid and megakaryocytic cell lines. Exp. Hematol. 1991; 19: 11–17
   PubMed Web of Science ®Google Scholar
• Yasunaga M., Ryo R., Yamaguchi N. Modulation of granulocytic-macrophage colony-stimulating factor receptor β subunit and interleukin-6 receptor mRNA in a human megakaryocytic leukemia cell line. Leuk. & Lymph. 1992, in press.
   Google Scholar
• Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/INFβ2) receptor. Science 1988; 241: 825–828
   PubMed Web of Science ®Google Scholar
• Ryo R., Yoshida A., Adachi M., Sugano W., Yasunaga M., Yoneda N., Yamaguchi N., Sato T. Cytologic calcium mobilization and thromboxane synthesis in a human megakaryocytic leukemia cell. Exp. Hematol. 1990; 18: 271–275
   PubMed Web of Science ®Google Scholar
• Yasunaga M., Ryo R., Sugano W., Yamaguchi N. Detection of platelet-specific protein mRNAs in various types of megakaryoblasts using the reverse transcriptase polymerase chain reaction. Leuk. & Lymph. 1992, in press.
   Google Scholar
• Ryo R., Proffit R. T., Poger M. E., O'Bear R., Deuel T. F. Platelet factor 4 antigen in megakaryocytes. Thromb. Res. 1980; 17: 645–652
   PubMed Web of Science ®Google Scholar
• Handagama P. J., Shuman M. A., Bainton D. F., Breton-Gorius J., Levin L., Nurden A. T., Williams N. The origin of platelet α-granule proteins. In Molecular Biology and Differentiation of Megakaryocytes. Wiley-Liss, Inc, New York 1990; 119–130
   Google Scholar
• Rabellino E. M., Levene R. B., Leung L. L. K., Nachman R. L. Human megakaryocytes II. Expression of platelet proteins in early marrow megakaryocytes. J. Exp. Med. 1981; 154: 88–100
   PubMed Web of Science ®Google Scholar
• Koike T. Megakaryoblastic leukemia: The characterization and identification of megakaryoblasts. Blood 1984; 64: 683–692
   PubMed Web of Science ®Google Scholar
• Erber W. N., Breton-Gorius J., Villeval J. L., Oscier D. G., Bai Y., Mason D. Y. Detection of cells of megakaryocyte lineage in haematological malignancies by immuno-alkaline phosphatase labelling cell smears with a panel of monoclonal antibodies. Brit. J. Haematol. 1987; 65: 87–94
   PubMed Web of Science ®Google Scholar
• Greenberg S. M., Chandrasekhar C. Hematopoietic factor-induced synthesis of von Willebrand factor by the Dami human megakaryoblastic cell line and by normal human megakaryocytes. Exp. Hematol. 1991; 19: 53–58
   PubMed Web of Science ®Google Scholar
• Alitalo R. Induced differentiation of K562 leukemia cells: A model for studies of gene expression in early megakaryoblasts. Leuk. Res 1990; 6: 501–514
   Web of Science ®Google Scholar
• Sunami S., Fuse A., Shimizu B., Eguchi M., Hayashi Y., Sugita K., Nakazawa S., Okimoto Y., Sato T., Nakajima H. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome. Blood 1987; 70: 368–371
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T., Raines E., Collins S., Nakamoto B., Tweeddale M., Ross R. Constitutive and inducible secretion of platelet-derived growth factor analogs by human leukemic cell lines coexpressing erythroid and megakaryocytic markers. J. Clin. Invest. 1987; 79: 859–866
   PubMed Web of Science ®Google Scholar
• Calamonici O. R., Trepel J. B., Vidal C. A., Neckers L. M. Phorbol ester induces c-sis gene transcription in stem cell line K-562. Mol. Cell. Biol. 1986; 6: 1847–1850
   PubMed Web of Science ®Google Scholar
• Weich H. A., Herbst D., Schairer H. U., Hoppe J. Platelet-derived growth factor. Phorbol ester induces the expression of the B-chain but not of the A-chain in HEL cells. FEBS Letters 1987; 213: 89–94
   PubMed Web of Science ®Google Scholar
• Alitalo R., Mäkelä T. P., Koskinen P., Anderson L. C., Alitalo K. Enhanced expression of transforming growth factor β during megakaryoblastic differentiation of K562 leukemic cells. Blood 1988; 71: 899–906
   PubMed Web of Science ®Google Scholar
• Zucker M. B., Katz I. R. Platelet factor 4: Production, structure, and physiologic and immunologic action. Soc. Exp. Biol. Med. 1991; 198: 693–702
   PubMed Web of Science ®Google Scholar
• Eisman R., Surrey S., Ramachandran B., Schwartz E., Poncz M. Structural and functional comparison of the genes for human platelet factor 4 and PF4alt. Blood 1990; 76: 336–344
   PubMed Web of Science ®Google Scholar
• Adachi M., Ryo R., Sato T., Yamaguchi N. Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line(CMK) and its differentiated subclone(CMK1 1–5). Exp. Hematol. 1991; 19: 923–927
   PubMed Web of Science ®Google Scholar
• Eguchi M., Sakakibara H., Suda J., Ozawa T., Hayashi Y., Sato T., Kojima S., Furukawa T. Ultra structural and ultra cytochemical differences between transient myeloproliferative disorder and megakryoblastic leukemia in Down's syndrome. Brit. J. Haematol. 1989; 7: 315–322, 3
   Web of Science ®Google Scholar
• Hegyi E., Heilbrun L. K., Nakeff A. lmmunogold probing of platelet factor 4 in different ploidy classes of rat megakaryocytes sorted by flow cytometry. Exp. Hematol. 1990; 18: 789–793
   PubMed Web of Science ®Google Scholar
• Gewirtz M., Calabretta B., Rucinski B., Niewiarowski S., Xu W. Y. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4(PF4) and a synthetic COOH-terminal PF4 peptide. J. Clin. Invest. 1989; 83: 1477–1486
   PubMed Web of Science ®Google Scholar
• Han Z. C., Sensébe L., Abgrall J. F., Brière J. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood 1990; 75: 1234–1239
   PubMed Web of Science ®Google Scholar
• Han Z. C., Bellucci S., Tenza D., Caen J. P. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: Comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaernia and immune thrombocytopenic purpura. Brit. J. Haematol. 1990; 74: 395–401
   PubMed Web of Science ®Google Scholar
• Hunt P., Hokom M. M., Fisher C. A., Jacobsen F. W., Wiemann B., Martin F. Platelet factor 4 mRNA expression in human erythroleukemic cells: Regulation by phorbol esters and certain cytokines. Exp. Hematol. 1991; 19: 719–784
   PubMedGoogle Scholar